GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greenfern Industries Ltd (NZSE:GFI) » Definitions » Debt-to-EBITDA

Greenfern Industries (NZSE:GFI) Debt-to-EBITDA : -0.36 (As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Greenfern Industries Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Greenfern Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was NZ$0.65 Mil. Greenfern Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was NZ$0.00 Mil. Greenfern Industries's annualized EBITDA for the quarter that ended in Mar. 2023 was NZ$-1.83 Mil. Greenfern Industries's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2023 was -0.36.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Greenfern Industries's Debt-to-EBITDA or its related term are showing as below:

NZSE:GFI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.36   Med: -0.36   Max: -0.36
Current: -0.36

During the past 2 years, the highest Debt-to-EBITDA Ratio of Greenfern Industries was -0.36. The lowest was -0.36. And the median was -0.36.

NZSE:GFI's Debt-to-EBITDA is ranked worse than
100% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs NZSE:GFI: -0.36

Greenfern Industries Debt-to-EBITDA Historical Data

The historical data trend for Greenfern Industries's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenfern Industries Debt-to-EBITDA Chart

Greenfern Industries Annual Data
Trend Mar22 Mar23
Debt-to-EBITDA
- -0.36

Greenfern Industries Semi-Annual Data
Mar22 Mar23
Debt-to-EBITDA - -0.36

Competitive Comparison of Greenfern Industries's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Greenfern Industries's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenfern Industries's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenfern Industries's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Greenfern Industries's Debt-to-EBITDA falls into.



Greenfern Industries Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Greenfern Industries's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.652 + 0) / -1.826
=-0.36

Greenfern Industries's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.652 + 0) / -1.826
=-0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Mar. 2023) EBITDA data.


Greenfern Industries  (NZSE:GFI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Greenfern Industries Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Greenfern Industries's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenfern Industries (NZSE:GFI) Business Description

Traded in Other Exchanges
N/A
Address
115 Queen Street, Level 8, General Capital House, Auckland, NTL, NZL, 1040
Greenfern Industries Ltd is committed to the environmentally friendly production of medicinal cannabis and hemp-based products. It operates in two segments, Cannabis and therapeutics products the operations of this segment reflect the activities of manufacture and distribution of cannabis products, Electricity generation this segment includes the generation and distribution of electricity. The hemp seed and its by-products are used for a range of different products from a high protein ingredient in a plant-based meat substitute, a hemp-based skincare range, and hemp-based beverages amongst other things.